[1]
N. A. . Vyawhare, “An FMEA-driven holistic approach to quality risk management for new product introduction in pharmaceutical commercial plant: navigating global regulatory landscapes”, Int. J. Res. Pharm. Sci., vol. 16, no. 3, pp. 24–45, Aug. 2025.